FinscoFinsco

CareDx (US.CDNA)

Capital Allocation Audit · Period: 2012 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.CDNA · YoY: 2026 H1 vs 2025 H1

MetricValueYoY
FCF Conversion83.8%↓
ROE26.7%↑
Cash Conversion30.8%→
D/E Ratio0.05↑
Gross Margin72.5%↑
US.CDNA (CareDx) | YoY: 2026 H1 vs 2025 H1


Metric           Value  YoY
---------------------------
FCF Conversion   83.8%    ↓
ROE              26.7%    ↑
Cash Conversion  30.8%    →
D/E Ratio         0.05    ↑
Gross Margin     72.5%    ↑
Key Metrics
US.CDNA (CareDx) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
---------------------------
FCF Conversion 83.8% ↓
ROE 26.7% ↑
Cash Conversion 30.8% →
D/E Ratio 0.05 ↑
Gross Margin 72.5% ↑

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies